XML 31 R62.htm IDEA: XBRL DOCUMENT v2.4.0.6
BUSINESS SEGMENTS (Details 2) (USD $)
3 Months Ended 9 Months Ended
Mar. 31, 2013
Mar. 31, 2012
Mar. 31, 2013
Mar. 31, 2012
Net sales $ 6,529,000 $ 7,522,000 $ 23,627,000 $ 22,940,000
Operating (loss) income (634,000) (933,000) (1,482,000) (3,460,000)
Total assets 32,456,000 36,865,000 32,456,000 36,865,000
Depreciation and amortization 613,000 676,000 1,879,000 2,041,000
Capital expenditures 602,000 270,000 1,367,000 1,402,000
Manufacturing [Member]
       
Net sales 2,786,000 3,969,000 11,157,000 9,983,000
Operating (loss) income (302,000) 10,000 (733,000) (570,000)
Total assets 9,770,000 12,047,000 9,770,000 12,047,000
Depreciation and amortization 34,000 50,000 124,000 158,000
Capital expenditures 8,000 2,000 27,000 10,000
Testing Services [Member]
       
Net sales 3,407,000 3,141,000 11,085,000 9,247,000
Operating (loss) income (93,000) (323,000) (23,000) (1,465,000)
Total assets 17,902,000 19,119,000 17,902,000 19,119,000
Depreciation and amortization 551,000 567,000 1,671,000 1,692,000
Capital expenditures 594,000 247,000 1,339,000 1,364,000
Distribution [Member]
       
Net sales 232,000 299,000 916,000 702,000
Operating (loss) income 35,000 42,000 119,000 51,000
Total assets 333,000 382,000 333,000 382,000
Depreciation and amortization    1,000 2,000 3,000
Capital expenditures       1,000   
RealEstate [Member]
       
Net sales 33,000 30,000 96,000 125,000
Operating (loss) income (56,000) (55,000) (177,000) (70,000)
Total assets 4,051,000 4,297,000 4,051,000 4,297,000
Depreciation and amortization 28,000 20,000 82,000 58,000
Capital expenditures    1,000    1,000
Fabrication [Member]
       
Net sales 71,000 83,000    
Operating (loss) income (146,000) (490,000)    
Total assets 269,000 952,000    
Depreciation and amortization    38,000    
Capital expenditures    20,000    
CorporateAndUnallocated [Member]
       
Net sales            
Operating (loss) income (72,000) (117,000) (64,000) (451,000)
Total assets 131,000 68,000 131,000 68,000
Depreciation and amortization            
Capital expenditures